Woods Robert Keith bought NGNE
January 16, 2024 · Form 4 insider transaction
Woods Robert Keith bought 15,400 shares of Neurogene Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,400
Price
$0.00
Total value
N/A
InsiderWoods Robert Keith
RoleDirector
CompanyNeurogene Inc. (NGNE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 16, 2024
Filing dateJanuary 18, 2024
Shares owned after15,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date.